_id
690f342fccc777a4e85d164f
Ticker
BEIGF
Name
BeiGene Ltd.
Exchange
PINK
Address
Aeschengraben 27, Basel, Switzerland, 4051
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://beonemedicines.com
Description
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of PARP1 and PARP2 enzymes that is being evaluated as a monotherapy and in combinations for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK-targeting chimeric degradation activation compound active against wild-type and mutant BTK; Ociperlimab (BGB-A1217), a TIGIT inhibitor; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.
Last Close
28.45
Volume
9
Current Price
25.2946
Change
0
Last Updated
2026-01-20T16:24:46.904Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
36387627008
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.6958888888888889
Sentiment Sources
9
Current Quarter
2025-09-30
Revenue
1412284000
Cost Of Revenue
196510000
Gross Profit
1215774000
Operating Expenses
1052660000
Operating Income
163114000
Interest Expense
-
Pretax Income
147164000
Net Income
124841000
Eps
0.08385623530807235
Dividends Per Share
-
Shares Outstanding
1323498003
Income Tax Expense
22323000
EBITDA
184448000
Operating Margin
11.549659983402771
Total Other Income Expense Net
-15950000
Cash
4036868000
Short Term Investments
-
Receivables
863281000
Inventories
531687000
Total Current Assets
5664477000
Property Plant Equipment
1768331000
Total Assets
7632586000
Payables
383676000
Short Term Debt
829028000
Long Term Debt
139571000
Total Liabilities
3503260000
Equity
4129326000
Bs_currency_symbol
USD
Depreciation
37284000
Change In Working Capital
100020000
Cash From Operations
402553000
Capital Expenditures
48084000
Cash From Investing
-49274000
Cash From Financing
961272000
Net Change In Cash
1324456000
Cf_currency_symbol
USD
PE
632.365
PB
9.119489404393937
ROE
3.0232778908712947
ROA
1.635631750497145
FCF
354469000
Fcf Percent
0.2509898858869746
Piotroski FScore
4
Health Score
61
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
4.5
Growth Investing Score
5.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
6
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1412284000
Quarters > 0 > income Statement > cost Of Revenue
196510000
Quarters > 0 > income Statement > gross Profit
1215774000
Quarters > 0 > income Statement > operating Expenses
1052660000
Quarters > 0 > income Statement > operating Income
163114000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
147164000
Quarters > 0 > income Statement > net Income
124841000
Quarters > 0 > income Statement > eps
0.08385623530807235
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1488750354
Quarters > 0 > income Statement > income Tax Expense
22323000
Quarters > 0 > income Statement > EBITDA
184448000
Quarters > 0 > income Statement > operating Margin
11.549659983402771
Quarters > 0 > income Statement > total Other Income Expense Net
-15950000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4036868000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
863281000
Quarters > 0 > balance Sheet > inventories
531687000
Quarters > 0 > balance Sheet > total Current Assets
5664477000
Quarters > 0 > balance Sheet > property Plant Equipment
1768331000
Quarters > 0 > balance Sheet > total Assets
7632586000
Quarters > 0 > balance Sheet > payables
383676000
Quarters > 0 > balance Sheet > short Term Debt
829028000
Quarters > 0 > balance Sheet > long Term Debt
139571000
Quarters > 0 > balance Sheet > total Liabilities
3503260000
Quarters > 0 > balance Sheet > equity
4129326000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
124841000
Quarters > 0 > cash Flow > depreciation
37284000
Quarters > 0 > cash Flow > change In Working Capital
100020000
Quarters > 0 > cash Flow > cash From Operations
402553000
Quarters > 0 > cash Flow > capital Expenditures
48084000
Quarters > 0 > cash Flow > cash From Investing
-49274000
Quarters > 0 > cash Flow > cash From Financing
961272000
Quarters > 0 > cash Flow > net Change In Cash
1324456000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.08385623530807235
Quarters > 0 > ratios > PB
9.119489404393937
Quarters > 0 > ratios > ROE
3.0232778908712947
Quarters > 0 > ratios > ROA
1.635631750497145
Quarters > 0 > ratios > FCF
354469000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.2509898858869746
Quarters > 0 > health Score
61
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1315300000
Quarters > 1 > income Statement > cost Of Revenue
164606000
Quarters > 1 > income Statement > gross Profit
1150694000
Quarters > 1 > income Statement > operating Expenses
1062809000
Quarters > 1 > income Statement > operating Income
87885000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
99549000
Quarters > 1 > income Statement > net Income
94320000
Quarters > 1 > income Statement > eps
0.06445804461651766
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1463277401
Quarters > 1 > income Statement > income Tax Expense
5229000
Quarters > 1 > income Statement > EBITDA
87885000
Quarters > 1 > income Statement > operating Margin
6.6817456093666845
Quarters > 1 > income Statement > total Other Income Expense Net
11664000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2756056000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
770776000
Quarters > 1 > balance Sheet > inventories
502867000
Quarters > 1 > balance Sheet > total Current Assets
4310221000
Quarters > 1 > balance Sheet > property Plant Equipment
1761561000
Quarters > 1 > balance Sheet > total Assets
6298394000
Quarters > 1 > balance Sheet > payables
360783000
Quarters > 1 > balance Sheet > short Term Debt
825644000
Quarters > 1 > balance Sheet > long Term Debt
146091000
Quarters > 1 > balance Sheet > total Liabilities
2527919000
Quarters > 1 > balance Sheet > equity
3770475000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
94320000
Quarters > 1 > cash Flow > depreciation
35614000
Quarters > 1 > cash Flow > change In Working Capital
5353000
Quarters > 1 > cash Flow > cash From Operations
263598000
Quarters > 1 > cash Flow > capital Expenditures
43826000
Quarters > 1 > cash Flow > cash From Investing
-66605000
Quarters > 1 > cash Flow > cash From Financing
35025000
Quarters > 1 > cash Flow > net Change In Cash
255495000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
0.06445804461651766
Quarters > 1 > ratios > PB
9.816539440610162
Quarters > 1 > ratios > ROE
2.501541582957054
Quarters > 1 > ratios > ROA
1.4975246070664998
Quarters > 1 > ratios > FCF
219772000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.16708887706226716
Quarters > 1 > health Score
58
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1117279000
Quarters > 2 > income Statement > cost Of Revenue
165002000
Quarters > 2 > income Statement > gross Profit
952277000
Quarters > 2 > income Statement > operating Expenses
941175000
Quarters > 2 > income Statement > operating Income
11102000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
20900000
Quarters > 2 > income Statement > net Income
1270000
Quarters > 2 > income Statement > eps
0.0008787387450890707
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1445253219
Quarters > 2 > income Statement > income Tax Expense
19630000
Quarters > 2 > income Statement > EBITDA
11102000
Quarters > 2 > income Statement > operating Margin
0.9936640713733992
Quarters > 2 > income Statement > total Other Income Expense Net
9798000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2516411000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
717239000
Quarters > 2 > balance Sheet > inventories
494660000
Quarters > 2 > balance Sheet > total Current Assets
3896492000
Quarters > 2 > balance Sheet > property Plant Equipment
1745004000
Quarters > 2 > balance Sheet > total Assets
5841526000
Quarters > 2 > balance Sheet > payables
364498000
Quarters > 2 > balance Sheet > short Term Debt
781773000
Quarters > 2 > balance Sheet > long Term Debt
160157000
Quarters > 2 > balance Sheet > total Liabilities
2342013000
Quarters > 2 > balance Sheet > equity
3499513000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1270000
Quarters > 2 > cash Flow > depreciation
32804000
Quarters > 2 > cash Flow > change In Working Capital
-78027000
Quarters > 2 > cash Flow > cash From Operations
44082000
Quarters > 2 > cash Flow > capital Expenditures
56407000
Quarters > 2 > cash Flow > cash From Investing
-121941000
Quarters > 2 > cash Flow > cash From Financing
-33777000
Quarters > 2 > cash Flow > net Change In Cash
-108156000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.0008787387450890707
Quarters > 2 > ratios > PB
10.446339840234169
Quarters > 2 > ratios > ROE
0.036290763886289316
Quarters > 2 > ratios > ROA
0.02174089441697255
Quarters > 2 > ratios > FCF
-12325000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
-0.01103126434847518
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1127824000
Quarters > 3 > income Statement > cost Of Revenue
160560000
Quarters > 3 > income Statement > gross Profit
967264000
Quarters > 3 > income Statement > operating Expenses
1207249000
Quarters > 3 > income Statement > operating Income
-79425000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-85351000
Quarters > 3 > income Statement > net Income
-151881000
Quarters > 3 > income Statement > eps
-0.10967398735880729
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1384840687
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-7.042322206301692
Quarters > 3 > income Statement > total Other Income Expense Net
-13734000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
2627410000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
676278000
Quarters > 3 > balance Sheet > inventories
494986000
Quarters > 3 > balance Sheet > total Current Assets
3991593000
Quarters > 3 > balance Sheet > property Plant Equipment
1644989000
Quarters > 3 > balance Sheet > total Assets
5920910000
Quarters > 3 > balance Sheet > payables
404997000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
166484000
Quarters > 3 > balance Sheet > total Liabilities
2588688000
Quarters > 3 > balance Sheet > equity
3332222000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-151881000
Quarters > 3 > cash Flow > depreciation
50246000
Quarters > 3 > cash Flow > change In Working Capital
-18862000
Quarters > 3 > cash Flow > cash From Operations
75160000
Quarters > 3 > cash Flow > capital Expenditures
92480000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-4523000
Quarters > 3 > cash Flow > net Change In Cash
-74681000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.10967398735880729
Quarters > 3 > ratios > PB
10.51220214061074
Quarters > 3 > ratios > ROE
-4.557949620403442
Quarters > 3 > ratios > ROA
-2.5651631252628393
Quarters > 3 > ratios > FCF
-17320000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.015357006057682759
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3810241000
Annuals > 0 > income Statement > cost Of Revenue
594089000
Annuals > 0 > income Statement > gross Profit
3216152000
Annuals > 0 > income Statement > operating Expenses
3784351000
Annuals > 0 > income Statement > operating Income
-568199000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-533001000
Annuals > 0 > income Statement > net Income
-644786000
Annuals > 0 > income Statement > eps
-0.47107763342171355
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1368746793
Annuals > 0 > income Statement > income Tax Expense
111785000
Annuals > 0 > income Statement > EBITDA
-568199000
Annuals > 0 > income Statement > operating Margin
-14.91241630122609
Annuals > 0 > income Statement > total Other Income Expense Net
35198000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2627410000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
676278000
Annuals > 0 > balance Sheet > inventories
494986000
Annuals > 0 > balance Sheet > total Current Assets
3991593000
Annuals > 0 > balance Sheet > property Plant Equipment
1717732000
Annuals > 0 > balance Sheet > total Assets
5920910000
Annuals > 0 > balance Sheet > payables
404997000
Annuals > 0 > balance Sheet > short Term Debt
869105000
Annuals > 0 > balance Sheet > long Term Debt
166484000
Annuals > 0 > balance Sheet > total Liabilities
2588688000
Annuals > 0 > balance Sheet > equity
3332222000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-644786000
Annuals > 0 > cash Flow > depreciation
171762000
Annuals > 0 > cash Flow > change In Working Capital
-157167000
Annuals > 0 > cash Flow > cash From Operations
-140631000
Annuals > 0 > cash Flow > capital Expenditures
492663000
Annuals > 0 > cash Flow > cash From Investing
-548350000
Annuals > 0 > cash Flow > cash From Financing
193449000
Annuals > 0 > cash Flow > net Change In Cash
-547237000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.47107763342171355
Annuals > 0 > ratios > PB
10.390034826676553
Annuals > 0 > ratios > ROE
-19.350031300435568
Annuals > 0 > ratios > ROA
-10.88998143866399
Annuals > 0 > ratios > FCF
-633294000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.16620838419407066
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2458779000
Annuals > 1 > income Statement > cost Of Revenue
379920000
Annuals > 1 > income Statement > gross Profit
2078859000
Annuals > 1 > income Statement > operating Expenses
3666515000
Annuals > 1 > income Statement > operating Income
-1207736000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-825836000
Annuals > 1 > income Statement > net Income
-881708000
Annuals > 1 > income Statement > eps
-0.6485468360549026
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1359513224
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-49.11933931435074
Annuals > 1 > income Statement > total Other Income Expense Net
307891000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3171800000
Annuals > 1 > balance Sheet > short Term Investments
2600000
Annuals > 1 > balance Sheet > receivables
358027000
Annuals > 1 > balance Sheet > inventories
416122000
Annuals > 1 > balance Sheet > total Current Assets
4203414000
Annuals > 1 > balance Sheet > property Plant Equipment
1389910000
Annuals > 1 > balance Sheet > total Assets
5805275000
Annuals > 1 > balance Sheet > payables
315111000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
197618000
Annuals > 1 > balance Sheet > total Liabilities
2267948000
Annuals > 1 > balance Sheet > equity
3537327000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-881708000
Annuals > 1 > cash Flow > depreciation
87675000
Annuals > 1 > cash Flow > change In Working Capital
-370539000
Annuals > 1 > cash Flow > cash From Operations
-1157453000
Annuals > 1 > cash Flow > capital Expenditures
596261000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
416478000
Annuals > 1 > cash Flow > net Change In Cash
-689053000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.6485468360549026
Annuals > 1 > ratios > PB
9.7215618448027
Annuals > 1 > ratios > ROE
-24.925826761280483
Annuals > 1 > ratios > ROA
-15.188048800444424
Annuals > 1 > ratios > FCF
-1753714000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.7132458834242524
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1415921000
Annuals > 2 > income Statement > cost Of Revenue
286475000
Annuals > 2 > income Statement > gross Profit
1129446000
Annuals > 2 > income Statement > operating Expenses
3205586000
Annuals > 2 > income Statement > operating Income
-1789665000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-1961037000
Annuals > 2 > income Statement > net Income
-2003815000
Annuals > 2 > income Statement > eps
-1.4775869261539025
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1356140180
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-126.3958229307991
Annuals > 2 > income Statement > total Other Income Expense Net
-223852000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
3869564000
Annuals > 2 > balance Sheet > short Term Investments
665251000
Annuals > 2 > balance Sheet > receivables
173168000
Annuals > 2 > balance Sheet > inventories
282346000
Annuals > 2 > balance Sheet > total Current Assets
5207078000
Annuals > 2 > balance Sheet > property Plant Equipment
972621000
Annuals > 2 > balance Sheet > total Assets
6379290000
Annuals > 2 > balance Sheet > payables
294781000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
209148000
Annuals > 2 > balance Sheet > total Liabilities
1995935000
Annuals > 2 > balance Sheet > equity
4383355000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2003815000
Annuals > 2 > cash Flow > depreciation
66278000
Annuals > 2 > cash Flow > change In Working Capital
132391000
Annuals > 2 > cash Flow > cash From Operations
-1496619000
Annuals > 2 > cash Flow > capital Expenditures
469099000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-18971000
Annuals > 2 > cash Flow > net Change In Cash
-507850000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.4775869261539025
Annuals > 2 > ratios > PB
7.825746123010342
Annuals > 2 > ratios > ROE
-45.714184682737304
Annuals > 2 > ratios > ROA
-31.411254230486463
Annuals > 2 > ratios > FCF
-1965718000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.3882963809421571
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1176283000
Annuals > 3 > income Statement > cost Of Revenue
164906000
Annuals > 3 > income Statement > gross Profit
1011377000
Annuals > 3 > income Statement > operating Expenses
2615018000
Annuals > 3 > income Statement > operating Income
-1438735000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-1438588000
Annuals > 3 > income Statement > net Income
-1457816000
Annuals > 3 > income Statement > eps
-1.0921571205239489
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1334804281
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-1392278000
Annuals > 3 > income Statement > operating Margin
-122.31197764483548
Annuals > 3 > income Statement > total Other Income Expense Net
15904000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4375678000
Annuals > 3 > balance Sheet > short Term Investments
2241962000
Annuals > 3 > balance Sheet > receivables
483113000
Annuals > 3 > balance Sheet > inventories
242626000
Annuals > 3 > balance Sheet > total Current Assets
7613880000
Annuals > 3 > balance Sheet > property Plant Equipment
686744000
Annuals > 3 > balance Sheet > total Assets
8535525000
Annuals > 3 > balance Sheet > payables
262400000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
202113000
Annuals > 3 > balance Sheet > total Liabilities
2402962000
Annuals > 3 > balance Sheet > equity
6132563000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1413354000
Annuals > 3 > cash Flow > depreciation
46457000
Annuals > 3 > cash Flow > change In Working Capital
-118345000
Annuals > 3 > cash Flow > cash From Operations
-1298723000
Annuals > 3 > cash Flow > capital Expenditures
314851000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
3636911000
Annuals > 3 > cash Flow > net Change In Cash
2992882000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.0921571205239489
Annuals > 3 > ratios > PB
5.505583940382284
Annuals > 3 > ratios > ROE
-23.77172480739293
Annuals > 3 > ratios > ROA
-17.079394647663733
Annuals > 3 > ratios > FCF
-1613574000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.3717566265941104
Annuals > 3 > health Score
29
Valuation > metrics > PE
632.365
Valuation > metrics > PB
9.119489404393937
Valuation > final Score
1
Valuation > verdict
1316.7% Overvalued
Profitability > metrics > ROE
3.0232778908712947
Profitability > metrics > ROA
2.203928094332451
Profitability > metrics > Net Margin
0.08839652647767729
Profitability > final Score
26
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8483854265805122
Risk > metrics > Interest Coverage
4.374906125952151
Risk > final Score
65
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.670947733329815
Liquidity > metrics > Quick Ratio
4.232516755943743
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
20
Prev Profitabilities > 0
22
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
78
Prev Risks > 1
53
Prev Risks > 2
25
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:28:36.660Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0839
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0645
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CNY
Earnings History > 3 > eps Actual
0.0009
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-24
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
CNY
Earnings History > 4 > eps Actual
-0.1099
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
-0.0881
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
-0.0885
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-08
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
-0.1853
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-26
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
-0.2717
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
0.1549
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
-0.2802
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
-0.2573
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-27
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
-0.33
Earnings History > 12 > eps Estimate
-0.57
Earnings History > 12 > eps Difference
0.24
Earnings History > 12 > surprise Percent
42.1053
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-05-05
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
-0.33
Earnings History > 13 > eps Estimate
-1.68
Earnings History > 13 > eps Difference
1.35
Earnings History > 13 > surprise Percent
80.3571
Earnings History > 14 > period
2021-06-30
Earnings History > 14 > report Date
2021-08-05
Earnings History > 14 > date
2021-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
-0.4
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-03-31
Earnings History > 15 > report Date
2021-05-06
Earnings History > 15 > date
2021-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
0.05
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2020-09-30
Earnings History > 16 > report Date
2020-11-05
Earnings History > 16 > date
2020-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
-0.37
Earnings History > 16 > eps Estimate
-4.06
Earnings History > 16 > eps Difference
3.69
Earnings History > 16 > surprise Percent
90.8867
Earnings History > 17 > period
2020-06-30
Earnings History > 17 > report Date
2020-08-06
Earnings History > 17 > date
2020-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
-0.33
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-03-31
Earnings History > 18 > report Date
2020-05-11
Earnings History > 18 > date
2020-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
-0.36
Earnings History > 18 > eps Estimate
-0.34
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-5.8824
Earnings History > 19 > period
2019-12-31
Earnings History > 19 > report Date
2020-02-26
Earnings History > 19 > date
2019-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
-0.49
Earnings History > 19 > eps Estimate
-0.39
Earnings History > 19 > eps Difference
-0.1
Earnings History > 19 > surprise Percent
-25.641
Earnings History > 20 > period
2019-09-30
Earnings History > 20 > report Date
2019-11-12
Earnings History > 20 > date
2019-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
-0.39
Earnings History > 20 > eps Estimate
-0.37
Earnings History > 20 > eps Difference
-0.02
Earnings History > 20 > surprise Percent
-5.4054
Earnings History > 21 > period
2019-06-30
Earnings History > 21 > report Date
2019-08-08
Earnings History > 21 > date
2019-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
-0.11
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and PARTRUVIX, a selective small molecule inhibitor of PARP1 and PARP2 enzymes that is being evaluated as a monotherapy and in combinations for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK-targeting chimeric degradation activation compound active against wild-type and mutant BTK; Ociperlimab (BGB-A1217), a TIGIT inhibitor; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIs Agilent Technologies, Inc.'s (NYSE:A) Latest Stock Performance Being Led By Its Strong Fundamentals? Yahoo Finance
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BeiGene Ltd.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.0839
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.